ClinicalTrials.gg
RecruitingNCT07662837Updated Aug 26, 2026

Effects of Tai Chi Therapy Versus Qi-Gong in Stage-I Parkinson's Patients.

An interventional study of Tai Chi and Qi Gong in PARKINSON DISEASE (Disorder), sponsored by Lahore University of Biological and Applied Sciences. Recruiting at 2 sites in Pakistan. Open to participants aged 50 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-08-26.

Sponsored by Lahore University of Biological and Applied Sciences · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started May 2026; still recruiting 5 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
50 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-20

Among 34 studies in Parkinson Disease with a site in Pakistan — 14 open to participants now, 15 under way, none of them phase 3. Parkinson Disease · Pakistan.

Planned enrollment
11th of 30
50 · median 42
Started
2026
with 8 others
No phase
30 of 34
14 open now
Primary completion
2026-08
later than 10 of 14 live
Registered
31st of 34
by date
Lead sponsor
3 of 34
Lahore University of Biological and Applied Sciences

Among the 34 studies in Parkinson Disease with a site in Pakistan, this one is the 11th largest by planned enrollment of the 30 interventional ones that give a count, is one of 9 that started in 2026, is one of 30 with no phase, reaches primary completion later than 10 of the 14 other live ones, and was the 31st registered.

Parkinson Disease

4,583 studies on the registry are indexed under Parkinson Disease; 1,086 are open to participants now.

Browse Parkinson Disease studies →

Open to participants now

14 of the 34 studies in Parkinson Disease with a site in Pakistan are open now. Recruiting first, the newest first:

8 more — sign in →

All 14 open studies →

A study can be open while its sites in Pakistan have not opened yet or have stopped. Only those recruiting at a site in Pakistan →

Who these studies take

Of the 752 Parkinson Disease studies recruiting now, 313 (42%) set no upper age limit and 127 (17%) stop at 75 or younger; 64 take children under 18; 189 take healthy volunteers.

This study: 50 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 34 studies in Parkinson Disease with a site in Pakistan, or all of them as a file.
02

Study summary

This study has important clinical, academic, and practical relevance in neuromuscular rehabilitation. Clinically, it aims to identify effective and tolerable rehabilitation strategies for individuals with Parkinson's disease by comparing Tai Chi Therapy with Qi-Gong there by supporting evidence-based physiotherapy practice and improving patient adherence. Academically, it contributes to the limited literature on comparative effectiveness of these interventions and incorporates patient-centered outcomes such as exercise perception, which are often underreported. From a practical and societal perspective, identifying a more acceptable and effective approach may enhance long-term participation in rehabilitation, potentially slow disease progression, and reduce the overall healthcare burden associated with Parkinson's disease.

Read the detailed description

Parkinson's disease is a progressive neurodegenerative disorder characterized by the loss of dopaminergic neurons in the substantia nigra, leading to motor symptoms such as tremor, rigidity, bradykinesia, and postural instability. The title of the present study focuses on evaluating the effectiveness of Tai Chi Therapy versus Qi-Gong on Postural Control, Functional Balance and Motor Function in individuals with Stage-I with Parkinson's disease. The study design is a randomized controlled trial with participants allocated into two groups. The study duration is expected to span 8 to 12 weeks, allowing sufficient time for neuromuscular adaptations and observable functional improvements while maintaining feasibility and participant compliance. Outcome measures include standardized and validated tools such as the Unified Parkinson's Disease Rating Scale for assessing disease severity, the Berge Balance Scale is use for the functional balance and postural control these measures are recorded at baseline and post-intervention to determine the effectiveness of the rehabilitation protocol, providing comprehensive insight into motor Motor Control, Functional Balance and Motor Function in individuals with Stage I Parkinson's disease.

03

Conditions studied

  • PARKINSON DISEASE (Disorder)

Browse trials for

Keywords

  • Tai Chi
  • Qi-Gong
04

Who can participate

Ages eligible
50 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosis of PD based on the Hoehn \& Yahr staging system (Stages I).
  • Male or female patients aged between 50-65 years.
  • Currently receiving stable anti-Parkinsonian medication, with no changes in the treatment regimen for at least 3 months.
  • Basic self-care ability with no severe cognitive impairment ( [MMSE] score ≥24).

Exclusion criteria

Exclusion Criteria:

  • Depression, as assessed based on a score of >16 for the Beck Depression Inventory-II (BDI-II).
  • Recent deep brain stimulation (DBS) treatment.
  • Use of medication that interferes with cognition, alertness, or attention.
  • Current participation in an exercise training program.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Tai Chi

    Tai Chi is a traditional Chinese "moving meditation" that combines slow, gentle movements with deep diaphragmatic breathing and focused attention. It is designed to cultivate inner energy and harmonize mind and body, making it a popular low-impact, therapeutic exercise.

    Other: Tai Chi

  • Experimental
    Qi Gong

    It is a holistic, low-impact mind-body practice that combines slow, flowing movements, deep rhythmic breathing, and focused intention to balance energy flow, improve health, and enhance overall vitality.

    Other: Qi Gong

Interventions

  • OtherTai Chi

    Group A will receive 8 weeks of standard conventional physical therapy plus Tai Chi (40 min of Tai Chi and 20 min of conventional physical therapy) total duration of session will be 60 minutes. The most commonly applied Tai Chi style will be Yang style.

  • OtherQi Gong

    Group B will receive 8 weeks of standard conventional physical therapy (20 minutes) plus Health Qigong Baduanjin and wuqinxi ( 40 minutes) with total duration of 60 minutes, 2 times a week each pattern for 8 weeks.

06

What researchers measure

Primary outcomes

  1. Unified Parkinson's Disease Rating Scale

    It will be used for motor function. UPDRS shows high ICCs like 0.90 for Motor, 0.85 for ADL).A higher score indicates greater motor impairment and disease severity. Total score is 108 across 27 items. It will be used at pre and post intervention.

    Time frame: 8-12 weeks

  2. Berg Balance Scale (BBS)

    The Berg Balance Scale (BBS) is a widely used clinical test with 14 functional tasks (like sitting, standing, reaching, turning) to measure static and dynamic postural control and functional balance, primarily to assess fall risk in older adults and neurological patients (stroke, Parkinson's). It scores tasks from 0 (unable) to 4 (independent) for a total of 56, with lower scores indicating higher fall risk, helping therapists plan interventions. It Shows very high intra-rater (same tester) and inter-rater (different testers) reliability, with Intraclass Correlation Coefficients (ICC) often around 0.97-0.99. The Berg Balance Scale have 14-item. Each item is scored on a 0-4 scale, with a total score of 56 points indicating no balance deficit and lower scores correlating with higher fall risk. The patients with the scores between 0-20 have High fall risk (may need wheelchair), 21-40: Medium fall risk (may need cane/walker) and 41-56: Low fall risk (independent mobility).

    Time frame: 8-12 weeks

07

Study locations

2 of 2 sites recruiting
  • Ghurki Trust and Teaching Hospital
    Lahore, Punjab Province, Pakistan
    Recruiting
    • Dr. Mir Shakeel Ahmad · Contact
  • The Meer's Physiotherapy and Rehabilitation
    Lahore, Pakistan
    Recruiting
08

References and documents

Publications

  • Xu F, Soh KG, Chan YM, Bai XR, Qi F, Deng N. Effects of tai chi on postural balance and quality of life among the elderly with gait disorders: A systematic review. PLoS One. 2023 Sep 28;18(9):e0287035. doi: 10.1371/journal.pone.0287035. eCollection 2023. PubMed 37768953 ↗
  • Song R, Grabowska W, Park M, Osypiuk K, Vergara-Diaz GP, Bonato P, Hausdorff JM, Fox M, Sudarsky LR, Macklin E, Wayne PM. The impact of Tai Chi and Qigong mind-body exercises on motor and non-motor function and quality of life in Parkinson's disease: A systematic review and meta-analysis. Parkinsonism Relat Disord. 2017 Aug;41:3-13. doi: 10.1016/j.parkreldis.2017.05.019. Epub 2017 May 25. PubMed 28602515 ↗
  • Fidan O, Seyyar GK, Aras B, Colak E, Aras O. The effect of Tai Chi and Qigong on health-related quality of life in Parkinson's disease: a systematic review and meta-analysis of systematic reviews. Int J Rehabil Res. 2019 Sep;42(3):196-204. doi: 10.1097/MRR.0000000000000358. PubMed 31116118 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2026 (actual). Primary completion is estimated for Aug 2026, 3 months after the start.

Of 1,295 non-industry interventional studies with no phase under Parkinson Disease, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 44. This study's planned 3 months is below that.

Counting every sponsor, half of 1,371 studies reached it within 25 months; a quarter within 11 and three quarters within 44.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 17, 2026
First posted
Jun 23, 2026
StartActual
May 30, 2026
Primary completionEst.
Aug 30, 2026
CompletionEst.
Oct 10, 2026
Last update
Aug 26, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 26, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07662837
Lead sponsor
Lahore University of Biological and Applied Sciences
Responsible party
Sponsor
First posted
Jun 23, 2026
Start date
May 30, 2026
Primary completion
Aug 30, 2026 (estimated)
Completion
Oct 10, 2026 (estimated)
Last update
Aug 26, 2026

Study contacts

Maryam Fayyaz
Contact
maryamfayyazawan@gmail.com
03374677916
Salwa Atta
Contact
03084579229
Salwa Atta
study director · Lahore University of Biological & Applied Sciences

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion